
Neuronetics Inc is a diagnostics & research business based in the US. Neuronetics shares (STIM) are listed on the NASDAQ and all prices are listed in US Dollars. Neuronetics employs 187 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Neuronetics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – STIM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Neuronetics stock price (NASDAQ: STIM)
Use our graph to track the performance of STIM stocks over time.Neuronetics shares at a glance
Latest market close | $3.54 |
---|---|
52-week range | $1.98 - $17.22 |
50-day moving average | $2.83 |
200-day moving average | $3.97 |
Wall St. target price | $9.67 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.32 |
Buy Neuronetics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Neuronetics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Neuronetics price performance over time
Historical closes compared with the close of $3.54 from 2022-06-28
1 week (2022-06-23) | -2.75% |
---|---|
1 month (2022-05-27) | 23.34% |
3 months (2022-03-28) | 18.00% |
6 months (2021-12-30) | -15.51% |
1 year (2021-06-30) | -77.90% |
---|---|
2 years (2020-06-30) | 83.42% |
3 years (2019-06-28) | 12.51 |
5 years (2017-06-26) | N/A |
Neuronetics financials
Revenue TTM | $57.2 million |
---|---|
Gross profit TTM | $43.7 million |
Return on assets TTM | -13.41% |
Return on equity TTM | -38.25% |
Profit margin | -59.7% |
Book value | $2.87 |
Market capitalisation | $90.5 million |
TTM: trailing 12 months
Neuronetics share dividends
We're not expecting Neuronetics to pay a dividend over the next 12 months.
Neuronetics share price volatility
Over the last 12 months, Neuronetics's shares have ranged in value from as little as $1.98 up to $17.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neuronetics's is 2.3058. This would suggest that Neuronetics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Neuronetics overview
Neuronetics, Inc. , a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Neuronetics in the news
Activist investor takes 13% stake in Malvern-based Neuronetics, seeks board seat
ClearPoint Neuro, Inc. (CLPT) Surges 7.6%: Is This an Indication of Further Gains?
Neuronetics, New Relic Stocks See Action From Activist Investors
Frequently asked questions
What percentage of Neuronetics is owned by insiders or institutions?Currently 3.946% of Neuronetics shares are held by insiders and 83.005% by institutions. How many people work for Neuronetics?
Latest data suggests 187 work at Neuronetics. When does the fiscal year end for Neuronetics?
Neuronetics's fiscal year ends in December. Where is Neuronetics based?
Neuronetics's address is: 3222 Phoenixville Pike, Malvern, PA, United States, 19355 What is Neuronetics's ISIN number?
Neuronetics's international securities identification number is: US64131A1051 What is Neuronetics's CUSIP number?
Neuronetics's Committee on Uniform Securities Identification Procedures number is: 64131A105
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert